- Release Date: 29/11/21 08:15
- Summary: VGI Health Technology partners with ENDRA Life Sciences in NAFLD/NASH Phase II Clinical Study (Price Sensitive)
- Price Sensitive: Yes
- Download Document 103.89KB
- Forums
- NSX - By Stock
- Ann:VGI Health Technology partners with ENDRA Life Sciences in NAFLD/NASH Phase II Clinical Study...
Ann:VGI Health Technology partners with ENDRA Life Sciences in NAFLD/NASH Phase II Clinical Study...
Featured News
Featured News
The Watchlist
FBM
FUTURE BATTERY MINERALS LIMITED
Nick Rathjen, MD & CEO
Nick Rathjen
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online